KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCash from Discontinued OperationsCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Depreciation and Depletion: 2011-2022

Historic Depreciation and Depletion for TherapeuticsMD (TXMD) over the last 12 years, with Dec 2022 value amounting to $600,000.

  • TherapeuticsMD's Depreciation and Depletion rose 200.00% to $200,000 in Q4 2022 from the same period last year, while for Dec 2022 it was $700,000, marking a year-over-year increase of 75.00%. This contributed to the annual value of $600,000 for FY2022, which is 50.00% up from last year.
  • According to the latest figures from FY2022, TherapeuticsMD's Depreciation and Depletion is $600,000, which was up 50.00% from $400,000 recorded in FY2021.
  • Over the past 5 years, TherapeuticsMD's Depreciation and Depletion peaked at $800,000 during FY2020, and registered a low of $181,412 during FY2018.
  • Its 3-year average for Depreciation and Depletion is $600,000, with a median of $600,000 in 2022.
  • Per our database at Business Quant, TherapeuticsMD's Depreciation and Depletion soared by 120.49% in 2019 and then plummeted by 50.00% in 2021.
  • TherapeuticsMD's Depreciation and Depletion (Yearly) stood at $181,412 in 2018, then soared by 120.49% to $400,000 in 2019, then skyrocketed by 100.00% to $800,000 in 2020, then tumbled by 50.00% to $400,000 in 2021, then skyrocketed by 50.00% to $600,000 in 2022.